Key result
Bovine bioprostheses are linked to ~2.4 mmHg lower 1-year gradients than porcine, with similar 10-year SVD.
Why the study?
Comparative longitudinal data on bovine and porcine bioprostheses after SAVR remain limited, particularly in Japanese patients with small aortic annuli.
Does the use of bovine pericardial bioprostheses improve mid-term hemodynamic performance and structural valve outcomes compared to porcine bioprostheses in patients undergoing surgical aortic valve replacement?
Cohort (n=351)
Does the use of bovine pericardial bioprostheses improve mid-term hemodynamic performance and structural valve outcomes compared to porcine bioprostheses in patients undergoing surgical aortic valve replacement?
Absolute Event Rate: 11.7% vs 14.1%
p-value: p=0.004
Bovine bioprostheses provide lower postoperative transvalvular gradients compared to porcine bioprostheses after surgical aortic valve replacement, though both offer comparable mid-term survival and freedom from structural valve deterioration.
Bovine valves were associated with lower gradients without SVD differences; leaves open optimal bioprosthesis selection pending randomized data.
Purpose Comparative longitudinal data on bovine and porcine bioprostheses after surgical aortic valve replacement (SAVR) remain limited, particularly in Japanese patients with small aortic annuli. We evaluated mid-term hemodynamic performance and structural valve outcomes using Valve Academic Research Consortium-3 (VARC-3) criteria. Methods We retrospectively reviewed 351 consecutive patients who underwent SAVR with conventional stented bioprostheses between 2012 and 2024. Patients receiving bovine (n = 180) or porcine (n = 171) bioprostheses were compared. Serial echocardiographic parameters and VARC-3-defined structural valve deterioration (SVD) were assessed. Propensity-score matching generated 62 matched pairs. Results In the matched cohort, the bovine group demonstrated lower mean transvalvular gradients at 1 year than the porcine group (11.7 ± 4.6 vs. 14.1 ± 5.2 mmHg, P = 0.004), and this difference persisted throughout follow-up. Overall survival was comparable between groups. Freedom from moderate SVD at 10 years did not differ significantly between groups (98.6% vs. 91.5%, P = 0.108). Subgroup analysis of 19-mm and 21-mm prostheses demonstrated comparable hemodynamic and valve-related outcomes. In the exploratory multivariable analysis, smaller prosthesis size was associated with SVD. Conclusion Both bovine and porcine bioprostheses demonstrated acceptable mid-term outcomes after SAVR. Bovine bioprostheses were associated with lower postoperative transvalvular gradients, whereas survival and severe valve-related events remained comparable between groups. Structural valve outcomes should be interpreted cautiously because of the limited number of events. Further studies with larger cohorts and longer follow-up are warranted to optimize prosthesis selection, particularly in patients requiring small surgical bioprostheses.
No takes yet. Share an insight, caveat, or question.
Kondo et al. (2026) conducted a cohort in Surgical aortic valve replacement (n=351). Bovine bioprostheses vs. Porcine bioprostheses was evaluated on Mean transvalvular gradients at 1 year (p=0.004). In a matched cohort, bovine bioprostheses had lower mean transvalvular gradients at 1 year than porcine bioprostheses (11.7 vs 14.1 mmHg, P=0.004), with similar 10-year freedom from moderate SVD.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: